Severe obesity is already a significant problem for many children, especially since obese children often become obese adults. Could the now popular weight-loss injection drugs be a solution for those ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

A recent study suggests that people taking the GLP-1 liraglutide experienced more bone loss than people who exercised during ...

Evidence shows that blockbuster weight-loss medications can reduce obesity even in children aged 6–11, but their long-term ...

For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication active agent.

Some people lose more weight on drugs like Ozempic, Wegovy and Saxenda than others, and a new study reveals why that might be.

USA: The findings from a recent retrospective cohort study involving 3,389 patients with obesity revealed the effectiveness ...

SEMAGLUTIDE. IS THERE BETTER KNOWN AS BRAND NAMES ... THANK YO Children who used the weight loss drug liraglutide in a ...

Recently, GLP-1 receptor agonist medications have been prescribed more commonly, in part due to their ability to produce ...

Recent studies suggest a potential link between semaglutide-based medications, such as Ozempic, and an increased risk of ...